🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pharmacokinetic Study in Healthy Volunteers

A Comparison of Fisetin Kinetics in Young and Old Adults NCT06796374NA1 site📍 Greifswald University Medicine Greifswald · Tests: Fisetin - Fasted condition, Fisetin - Fed condition To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers NCT07514780Phase 11 site📍 Seoul JW Pharmaceutical · Tests: JW0061 SAD, JW0061 MAD, Placebo A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers NCT07682948Phase 11 site📍 Anyang Korea United Pharm. Inc. · Tests: Investigational Product 1, Investigational Product 2, Investigational Product 1 + Investigational Product 2 A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity NCT07437079Phase 11 site📍 Lenexa Novo Nordisk A/S · Tests: NNC6989-0001, Placebo (NNC6989-0001) A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment NCT07807059Phase 11 site📍 Chengdu Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS-4729 A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis NCT07038720Phase 11 site📍 Hangzhou Usynova Pharmaceuticals Ltd. · Tests: UA026, Placebo Phase I Study of HXN6005 in Adult Healthy Participants NCT07449741Phase 11 site📍 Bayswater Helixon Biotechnology (Suzhou) Co., Ltd · Tests: HXN6005, Placebo HS-10542 Study in Healthy Participants NCT07040046Phase 11 site📍 Qingdao Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: HS-10542, HS-10542 Placebo, HS-10542, HS-10542 Placebo A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar Extraction NCT07905105Phase 1, Phase 21 site📍 Salt Lake City Cytogel Pharma, LLC · Tests: CYT-1010, Placebo A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function NCT07694869Phase 11 site📍 Hefei CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: ammoxetine hydrochloride enteric-coated tablets A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet NCT07374224Phase 11 site📍 Beijing Guangzhou Lupeng Pharmaceutical Company LTD. · Tests: Rocbrutinib tablets, Itraconazole capsules, Rifampicin capsules A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects. NCT05620940Phase 11 site📍 Herston Inventage Lab., Inc. · Tests: Vivitrol Injectable Product, IVL3004, IVL4002 Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical Spray in Healthy Volunteers NCT06859281Phase 11 site📍 Saint Petersburg Valenta Pharm JSC · Tests: Grammidin neo, Grammidin, a metered dose topical spray A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants NCT06655870Phase 11 site📍 Melbourne ModernaTX, Inc. · Tests: mRNA-0184 Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults NCT07161180Phase 11 site📍 Seoul Pharmbio Korea Co., Ltd. · Tests: PBK_M2301 (levodropropizine + Pelargonium sidoides extract), R1_PBK_M2301 (levodropropizine), R2_PBK_M2301 (Pelargonium… A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years NCT07413666Phase 11 site📍 Lincoln Centessa Pharmaceuticals (UK) Limited · Tests: ORX489 Tablets, Placebo Tablets A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants NCT07800897Phase 11 site📍 Québec Bristol-Myers Squibb · Tests: Navlimetostat, Itraconazole, Rifampin, Midazolam, Pantoprazole IBI3042 Study in Healthy Participants and Overweight or Obese Participants NCT07793019Phase 11 site📍 Beijing Innovent Biologics (Suzhou) Co. Ltd. · Tests: Orforglipron, Matching Placebo, IBI3042 A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers NCT07162441Phase 11 site📍 Seoul Korea United Pharm. Inc. · Tests: treatment A, treatment B, treatment C Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers NCT06859333Phase 11 site📍 Moscow Valenta Pharm JSC · Tests: Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-… A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects NCT05913752Phase 1, Phase 24 sites📍 New Haven📍 Baltimore📍 Jerusalem Clearmind Medicine Inc. · Tests: CMND-100 Nalmefene Implant in Healthy Subjects NCT07325279Phase 11 site📍 Morrisville ReacX Pharmaceuticals, Inc. · Tests: 1 Nalmefene implant, 2 Nalmefene implants A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function NCT07694843Phase 11 site📍 Suzhou CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: ammoxetine hydrochloride enteric-coated tablets A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants NCT07784699Phase 11 site📍 Beijing Gan & Lee Pharmaceuticals. · Tests: GZC8072 Tablets, Placebo A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers NCT07474545Phase 11 site📍 Changsha Hunan Kelun Pharmaceutical Co., Ltd. · Tests: KL0011034 injection, Placebo, Etomidate Injectable Emulsion Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol NCT07269873Phase 11 site📍 Miami BioCorRx Pharmaceuticals Inc · Tests: BICX104 naltrexone implantable pellet, Bupropion 150 mg XL, Naltrexone (depot) A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes NCT07270731Phase 11 site📍 Neuss Novo Nordisk A/S · Tests: NNC9733-0001, Placebo Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects NCT06701110Phase 11 site📍 Suzhou Shanghai Jiatan Pharmatech Co., Ltd · Tests: [U-14C] WX-081 to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban NCT07265466Phase 11 site📍 Seongnam-si Onconic Therapeutics Inc. · Tests: JP-1366 and clopidogrel, JP-1366 and aspirin, JP-1366 and atorvastatin, JP-1366 and apixaban A Study to Assess the Absolute Bioavailability of Empasiprubart SC Administered With an Autoinjector and the Pharmacokinetic Noninferiority of Empasiprubart SC Versus Intravenous (IV) in Healthy Adult Participants NCT07612020Phase 11 site📍 Mount Royal argenx · Tests: empasiprubart SC AI, empasiprubart IV
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy